NWA
TTOO

Navis Wealth Advisors’s T2 Biosystems, Inc TTOO Stock Holding History

Navis Wealth Advisors’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2
Closed -$1K – 97
2022
Q3 		$1K Hold
2
– – ﹤0.01% 80
2022
Q2 		$2K Hold
2
– – ﹤0.01% 97
2022
Q1 		$5K Hold
2
– – ﹤0.01% 104
2021
Q4 		$5K Hold
2
– – ﹤0.01% 104
2021
Q3 		$9K Hold
2
– – 0.01% 125
2021
Q2 		$12K Buy
+2
New +$12.9K 0.01% 104

Other funds holding TTOO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ML
McAdam LLC Philadelphia, Pennsylvania $2.22B AUM 16.98% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Navis Wealth Advisors's TTOO Position: Q4 2022 in Review

Navis Wealth Advisors sold out of T2 Biosystems, Inc (TTOO) in Q4 2022, closing a stake of 2 shares — an estimated $1K sold.

Navis Wealth Advisors first reported a position in TTOO in Q2 2021 and held it in 6 quarters. The position peaked at $12K in Q2 2021. 20 funds tracked by Wall St. Rank hold TTOO as of Q4 2022.

  • Navis Wealth Advisors reported no remaining T2 Biosystems, Inc position as of Q4 2022 after selling out during the quarter.
  • Navis Wealth Advisors sold 2 T2 Biosystems, Inc shares in Q4 2022, an estimated $1K.
  • Navis Wealth Advisors first reported a position in T2 Biosystems, Inc in Q2 2021 and held it in 6 quarters.
  • Navis Wealth Advisors's T2 Biosystems, Inc position peaked at $12K in Q2 2021.
  • 20 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2022.

Based on Navis Wealth Advisors's 13F filing for Q4 2022, filed 25 Jan 2023.